ANIP Insider Transactions — Page 2
433 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Gutwerg Ori | SVP, GENERICS | 2024-06-05 | Sale | 2,985.0 | $67.0 |
| CAREY STEPHEN P. | SVP & CFO | 2024-06-04 | Sale | 5,000.0 | $63.58 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-06-03 | Sale | 20,000.0 | $64.41 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2024-05-21 | Sale | 2,000.0 | $61.61 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-05-20 | Sale | 12,855.0 | $61.81 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-05-17 | Sale | 5,836.0 | $62.09 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-05-16 | Sale | 16,459.0 | $63.84 |
| TANNENBAUM RENEE P | Director | 2024-05-16 | Sale | 2,000.0 | $63.87 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-05-15 | Sale | 14,850.0 | $65.86 |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-05-14 | Sale | 16,669.0 | $66.1 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-05-13 | Sale | 250.0 | $67.69 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-05-01 | Sale | 20,000.0 | $66.62 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-19 | Sale | 16,809.0 | $65.17 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-18 | Sale | 10,423.0 | $64.98 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-17 | Sale | 9,520.0 | $65.4 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-16 | Sale | 5,834.0 | $66.2 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-15 | Sale | 7,414.0 | $66.33 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-04-12 | Sale | 250.0 | $67.79 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-04-01 | Sale | 20,000.0 | $67.25 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-03-13 | Sale | 250.0 | $66.54 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-03-11 | Sale | 20,000.0 | $65.81 |
| CAREY STEPHEN P. | SVP & CFO | 2024-03-11 | Sale | 7,787.0 | $65.55 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-08 | Sale | 10,000.0 | $67.17 |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-03-08 | Sale | 16,292.0 | $67.13 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-07 | Sale | 15,085.0 | $66.35 |
| Marken James G. | SVP OPS & PROD DEV | 2024-03-07 | Sale | 24,338.0 | $66.37 |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-03-06 | Sale | 28,965.0 | $65.52 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-06 | Sale | 14,822.0 | $65.47 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-05 | Sale | 10,093.0 | $65.35 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2024-03-05 | Sale | 5,000.0 | $66.0 |
| Pera Antonio R | Director | 2024-03-04 | Sale | 7,000.0 | $65.2 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-02-13 | Sale | 250.0 | $56.04 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-23 | Sale | 15,000.0 | $56.44 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-22 | Sale | 5,692.0 | $55.95 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-19 | Sale | 4,524.0 | $55.57 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-18 | Sale | 9,784.0 | $55.3 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-17 | Sale | 10,000.0 | $55.11 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-16 | Sale | 5,000.0 | $55.63 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-01-12 | Sale | 250.0 | $56.43 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-12-19 | Sale | 25,000.0 | $52.65 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-12-18 | Sale | 13,026.0 | $52.44 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-12-15 | Sale | 11,974.0 | $52.44 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2023-12-11 | Sale | 250.0 | $49.21 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-17 | Sale | 13,000.0 | $51.0 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-16 | Sale | 6,448.0 | $51.66 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-16 | Sale | 6,448.0 | $51.66 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-15 | Sale | 7,647.0 | $53.64 |
| Davis Krista | SVP, CHIEF HR OFFICER | 2023-11-15 | Sale | 2,622.0 | $53.81 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-15 | Sale | 7,647.0 | $53.64 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-14 | Sale | 22,905.0 | $53.17 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-14 | Sale | 22,095.0 | $53.17 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2023-11-13 | Sale | 250.0 | $52.03 |
| Mutz Christopher | HEAD OF RARE DISEASE | 2023-11-10 | Sale | 3,000.0 | $52.47 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-19 | Sale | 10,000.0 | $57.06 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-18 | Sale | 6,242.0 | $57.78 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-17 | Sale | 8,758.0 | $58.53 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-16 | Sale | 13,063.0 | $58.31 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-13 | Sale | 11,937.0 | $57.58 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-10-02 | Sale | 20,000.0 | $56.48 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-09-19 | Sale | 25,333.0 | $61.23 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-09-18 | Sale | 8,425.0 | $61.64 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-09-15 | Sale | 16,242.0 | $62.81 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-09-01 | Sale | 20,000.0 | $64.7 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-29 | Sale | 25,000.0 | $63.37 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-28 | Sale | 25,000.0 | $63.06 |
| Gutwerg Ori | SVP, GENERICS | 2023-08-23 | Sale | 2,059.0 | $62.39 |
| Gutwerg Ori | SVP, GENERICS | 2023-08-23 | Sale | 13,502.0 | $62.39 |
| Marken James G. | SVP OPS & PROD DEV | 2023-08-23 | Sale | 3,932.0 | $63.0 |
| MERIDIAN VENTURE PARTNERS II LP | TenPercentOwner | 2023-08-16 | Sale | 200,000.0 | $58.5 |
| Brown Robert E. JR | TenPercentOwner | 2023-08-16 | Sale | 200,000.0 | $58.5 |
| Meridian Venture Partners II, Co. | TenPercentOwner | 2023-08-16 | Sale | 200,000.0 | $58.5 |
| Meridian Venture Partners II GP, L.P. | TenPercentOwner | 2023-08-16 | Sale | 200,000.0 | $58.5 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-15 | Sale | 22,110.0 | $61.6 |
| Lalwani Nikhil | PRESIDENT & CEO | 2023-08-15 | Sale | 11,616.0 | $61.13 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-14 | Sale | 27,890.0 | $61.15 |
| CAREY STEPHEN P. | SVP & CFO | 2023-08-14 | Sale | 17,639.0 | $61.37 |
| Pera Antonio R | Director | 2023-08-14 | Sale | 3,000.0 | $60.37 |
| Lalwani Nikhil | PRESIDENT & CEO | 2023-08-11 | Sale | 56,666.0 | $57.75 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-08-01 | Sale | 20,000.0 | $51.06 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-21 | Sale | 11,500.0 | $52.56 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-20 | Sale | 6,000.0 | $51.52 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-19 | Sale | 5,969.0 | $51.48 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-18 | Sale | 6,700.0 | $51.84 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-17 | Sale | 9,831.0 | $51.06 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-14 | Sale | 10,000.0 | $50.43 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-07-03 | Sale | 20,000.0 | $53.43 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-23 | Sale | 10,000.0 | $51.49 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-22 | Sale | 13,500.0 | $51.38 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-06-22 | Sale | 20,000.0 | $51.32 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-22 | Sale | 13,500.0 | $51.38 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-21 | Sale | 11,843.0 | $51.95 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-21 | Sale | 11,843.0 | $51.95 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-20 | Sale | 14,657.0 | $51.93 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-20 | Sale | 14,657.0 | $51.93 |
| MERIDIAN VENTURE PARTNERS II LP | TenPercentOwner | 2022-12-01 | Sale | 200,000.0 | $38.5 |
| Brown Robert E. JR | Director | 2022-12-01 | Sale | 200,000.0 | $38.5 |
| Meridian Venture Partners II, Co. | TenPercentOwner | 2022-12-01 | Sale | 200,000.0 | $38.5 |
| Meridian Venture Partners II GP, L.P. | TenPercentOwner | 2022-12-01 | Sale | 200,000.0 | $38.5 |
| Marken James G. | SVP OPS & PROD DEV | 2022-08-15 | Sale | 5,172.0 | $37.79 |
| Marken James G. | SVP OPS & PROD DEV | 2022-08-12 | Sale | 12,894.0 | $37.04 |